Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12.7Revenue (TTM) $M11.0Net Margin (%)-164.4Altman Z-Score-13.0
Enterprise Value $M4.8EPS (TTM) $-1.0Operating Margin %-149.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-164.1Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %-43.7Quick Ratio4.2Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %-52.4Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-89.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-106.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.9ROIC % (ttm)-196.6Gross Margin Increase y-yY

Gurus Latest Trades with ROSG

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

ROSG is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ROSG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ROSG :

Quarterly/Annual Reports about ROSG:

    News about ROSG:

    Articles On GuruFocus.com
    Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $ Dec 08 2008 

    More From Other Websites
    Rosetta Genomics to Present at the 9th Annual LD Micro Main Event Dec 01 2016
    Q3 2016 Rosetta Genomics Ltd Earnings Release - After Market Close Nov 30 2016
    Rosetta Genomics Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement... Nov 23 2016
    Rosetta Genomics Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement... Nov 23 2016
    Rosetta Genomics Enters Research Collaboration using microRNA Biomarkers to Predict Response to... Nov 21 2016
    Clinical Validation Study for RosettaGX Reveal Published in the Journal of Clinical Pathology Oct 27 2016
    Clinical Validation Study for RosettaGX Reveal Published in the Journal of Clinical Pathology Oct 27 2016
    RosettaGX Reveal Analytical Validation Study Featured on the Cover of the October Issue of Cancer... Oct 26 2016
    RosettaGX Reveal™ Analytical Validation Study Featured on the Cover of the October Issue of Cancer... Oct 24 2016
    Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer Oct 20 2016
    Rosetta Genomics Fortifies Intellectual Property Portfolio with Two New Patent Allowances for its... Oct 11 2016
    Rosetta Genomics Fortifies Intellectual Property Portfolio with Two New Patent Allowances for its... Oct 03 2016
    Rosetta Genomics Enters Distribution Agreement for RosettaGX Reveal™ in Israel with Rhenium Sep 29 2016
    Edited Transcript of ROSG earnings conference call or presentation 26-Sep-16 8:30pm GMT Sep 27 2016
    Rosetta Genomics Reports 2016 Second Quarter Financial Results Sep 26 2016
    Rosetta Genomics Reports 2016 Second Quarter Financial Results Sep 26 2016
    Q2 2016 Rosetta Genomics Ltd Earnings Release - After Market Close Sep 26 2016
    Rosetta Genomics to Host 2016 Second Quarter Financial Results and Business Update Conference Call... Sep 20 2016
    Rosetta Genomics to Host 2016 Second Quarter Financial Results and Business Update Conference Call... Sep 20 2016
    Rosetta Genomics to Present at Upcoming September Conferences Sep 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)